Zydus Cadila gets USFDA approval to market generic version of Deferasirox tablets
Posted by
www.biotecnika.org
Zydus Cadila, part of Cadila Healthcare group, on Tuesday said it has
received final approval from the US health regulator to market its
generic version of Deferasirox tablets used in treatment of chronic
iron overload due to blood transfusions.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-approval-to-market-generic-version-of-deferasirox-tablets/articleshow/76399918.cms
Subscribe to:
Post Comments (Atom)
Post a Comment